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Han JA, Seo EY, Kim HJ, Park SJ, Yoo HY, Kim JY, Shin DM,
Kim JK, Zhang YH, Kim SJ. Hypoxia-augmented constriction of
deep femoral artery mediated by inhibition of eNOS in smooth
muscle. Am J Physiol Cell Physiol 304: C78–C88, 2013. First pub-
lished October 24, 2012; doi:10.1152/ajpcell.00176.2012.—In con-
trast to the conventional belief that systemic arteries dilate under
hypoxia, we found that -adrenergic contraction of rat deep femoral
artery (DFA) is largely augmented by hypoxia (HVCDFA) while
hypoxia (3% PO2) alone had no effect. HVCDFA was consistently
observed in both endothelium-intact and -denuded vessels with partial
pretone by phenylephrine (PhE) or by other conditions (e.g., K
channel blocker). Patch-clamp study showed no change in the mem-
brane conductance of DFA myocytes by hypoxia. The RhoA-kinase
inhibitor Y27632 attenuated HVCDFA. The nitric oxide synthase
inhibitor [nitro-L-arginine methyl ester (L-NAME)] and soluble guan-
ylate cyclase inhibitor [oxadiazole quinoxalin (ODQ)] strongly aug-
mented the PhE-pretone, while neither of the agents had effect without
pretone. NADPH oxidase type 4 (NOX4) inhibitors (diphenylene
iodonium and plumbagin) also potentiated PhE-pretone, which was
reversed by NO donor. No additive HVCDFA was observed under the
pretreatment with L-NAME, ODQ, or plumbagin. Western blot and
immunohistochemistry analysis showed that both NOX4 and endo-
thelial nitric oxide synthase (eNOS) are expressed in smooth muscle
layer of DFA. Various mitochondria inhibitors (rotenone, myxothia-
zol, and cyanide) prevented HVCDFA. From the pharmacological data,
as a mechanism for HVCDFA, we suggest hypoxic inhibition of eNOS
in myocytes. The putative role of NOX4 and mitochondria requires
further investigation. The HVCDFA may prevent imbalance between
cardiac output and skeletal blood flow under emergent hypoxia
combined with increased sympathetic tone.
hypoxia/anoxia; arteries; smooth muscle; NADPH oxidase; nitric
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MULTIPLE REGULATORY MECHANISMS play roles matching tissue
perfusion and its metabolic needs. In skeletal muscle, the
change of blood flow rate in response to the muscular activity
is very high; 20- to 30-fold increases in blood flow rate/tissue
weight (25). During sustained heavy exercise, whole body
exercise capacity is critically dependent on the maximal rate of
oxygen delivery to tissues. However, considering the limited
volume of effective arterial circulation and relatively large
mass of skeletal muscles, general vasodilation of skeletal
arteries would be a potential threat to blood pressure regula-
tion, potentially leading to hypoperfusion of vital organs (7).
Therefore, it is postulated that a partial vasoconstriction of
skeletal arteries during strenuous whole body exercise (in-
creased sympathetic neural activity with hypoxic condition)
might occur, especially in the functionally less active muscular
area (14, 16). However, it has not been yet rigorously investi-
gated whether and how hypoxic conditions combined with
sympathetic stimulation regulate the contractility of skeletal
arteries.
It is generally accepted that hypoxia induces acute vasore-
laxation (HVR) of systemic arteries such as coronary and renal
arteries (33, 34, 36). A video analysis of cremaster arteries in
situ, a popular model for skeletal microcirculation, demon-
strated hypoxic vasodilation (19). Isometric contraction studies
of chicken femoral arteries reported prominent HVR (36).
However, this hypoxic effect was observed on top of the full
contraction induced by 80 mM KCl, which might have pref-
erentially allowed vasorelaxation (36).
Marked decreases of blood flow and luminal diameter were
observed in gastrocnemious arteries in an in vivo human study
during severe hypoxemia (3). In fact, previous isometric ten-
sion studies using dog femoral arteries demonstrated that
anoxia induces constriction (9, 24). Such varied results indicate
that the hypoxic regulation of skeletal artery requires further
investigation especially regarding the level of hypoxia and
accompanying pretone conditions.
We previously characterized the deep femoral artery (DFA;
diameter: 150–200 m) of rats as a model of small feeding
artery having prominent myogenic tone at physiological lumi-
nal pressure (40–100 mmHg; Refs. 2, 15). In a pilot study
using DFA, we found that hypoxia (PO2, 3–6%) consistently
induces strong vasoconstriction when pretreated with phenyl-
ephrine (PhE), an -adrenergic agonist. Since the hypoxic
augmentation of DFA contraction (HVCDFA) might have a
physiological action of redirecting skeletal blood flow to active
muscles under systemic hypoxia, we investigated its properties
and underlying mechanisms.
MATERIALS AND METHODS
Preparation of DFAs and isometric tension measurement. This
investigation conforms to the Guide for the Care and Use of Labo-
ratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996) and also conforms to
Seoul National University College of Medicine guidelines for the care
and use of animals (Insistuional Review Board Approval No. SNU-
100209-1). Male Sprague-Dawley rats (250–300 g) were anesthetized
with pentobarbital sodium (60–100 mg/kg ip). After full anesthesia
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was confirmed, rats were quickly killed by cervical dislocation, and
their proximal hindlimbs were dissected in ice-cold normal Tyrode’s
(NT) solution for the isolation of DFA. The DFA used in this study
was a segment of skeletal artery located between the adductor magnus
and gastrocnemius (15). In some rats, coronary arteries, middle
cerebral arteries, and renal arteries were also dissected to be compared
with DFA. The NT solution contained the following (in mmol/l): 140
NaCl, 5.4 KCl, 0.33 NaH2PO4, 10 HEPES, 10 glucose, 1 CaCl2, and
1 MgCl2, adjusted to pH 7.4 with NaOH.
A segment of artery was mounted on two 25-m wires in a
Mulvany-type myograph (Myo-Interface model 410A; DMT, Aarhus,
Denmark) and stabilized in physiological salt solution (PSS) contin-
uously gassed with 74% N2-21% O2-5% CO2 at 37°C. The PSS used
in myograph experiment consisted of the following (in mM): 118
NaCl, 4 KCl, 0.44 NaH2PO4, 24 NaHCO3, 1.8 CaCl2, 1 MgSO4, and
5.6 glucose. Before the experiments, the viability of the arteries was
evaluated by a strong contraction in response to 80 mM KCl-PSS
(80-K contraction). The 80 mM KCl-PSS were prepared by equimolar
substitution with NaCl in PSS. To induce hypoxic conditions, the O2
fraction of bubbling gas was lowered to 3% O2 by substitution with
N2. PO2 (%) was measured using a micro-oxygen electrode (MI-730;
Microelectrodes, Bedford, NH) to confirm that the PO2 (%) was
actually lowered to 3%.
Western blot analysis. Dissected DFAs were washed with ice-cold
PBS and lysed with a lysis buffer [50 mM Tris·HCl pH 7.4, 2 mM
EDTA, 100 mM NaCl, 1% Triton X-100, and protease inhibitor
cocktail (Roche, Germany)]. Lysates were homogenized in a dounce
homogenizer on ice. Extracts were clarified by centrifugation at
13,000 g for 15 min at 4°C. Supernatants were denatured using 5
SDS loading buffer and separated by gel electrophoresis on a 6.5%
SDS-polyacrylamide gel. The separated proteins were transferred to a
PVDF, and the protein levels were detected using following primary
antibodies; rabbit anti-NOX4 (EPITOMICS, Burlingame, CA), mouse
anti-endothelial nitric oxide synthase (eNOS) (BD Biosciences San
Diego, CA), and rabbit anti-inducible nitric oxide synthase (iNOS)
(NOVUS Biologicals, Littleton, CO). Bands were visualized using a
Fig. 1. Augmentation of partial contraction by
acute hypoxia in deep femoral artery (DFA).
A: representative trace of hypoxic vasocon-
striction of deep femoral artery (HVCDFA). In
each vessel, after confirming depolarization-
induced contraction by 80 mM KCl (80 K), a
partial pretone was induced by 1 M phenyl-
ephrine (PhE). Additional hypoxia (3% PO2,
H) induced sustained contraction that was
equivalent to 80-K contraction. On reoxygen-
ation, a transient relaxation and phasic contrac-
tion were observed. B: summary of DFA tones
under PhE pretreatment, additional hypoxia,
and reoxygenation (N) that were normalized to
the 80-K contraction (%80 K); 177 arteries
(DFA) were tested (number in bars). Through-
out Figs. 2–10, numbers of subjects are indi-
cated in the bars. C: concentration-dependent
contractions of DFA by PhE under normoxia
and hypoxia (n  5–7). D: comparison of
HVCDFA induced by various PO2 (6, 3, and
0%). E–H: effects of hypoxia (3% PO2) on
serotonin (5-HT)-induced pretone in various
systemic arteries (deep femoral, cerebral, cor-
onary, and renal arteries). Representative
traces among 5 cases for each type of artery are
shown.
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horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (Millipore,
Darmstadt, Germany) and HRP-conjugated anti-mouse IgG (Cell
Signaling, Danvers, MA) in conjunction with SuperSignal West Pico.
(Thermo Scientific, Meridian, MS). As positive control for the ex-
pression of NOX4 and eNOS, cardiac muscle was used. For iNOS,
HEK 293 cells were transfected with human iNOS cDNA using
FuGEN-6 (Roche Applied Science, Seoul, Korea).
Immunohistochemistry. Tissues from the deep femoral artery
were fixed in 4% paraformaldehyde, paraffin embedded, and then
cut into sections. Endogenous peroxidase was quenched with 3%
hydrogen peroxide for 5 min at room temperature. Primary anti-
bodies were diluted in antibody diluents (Invitrogen, Grand Island,
NY): monoclonal rabbit anti-NOX4 (EPITOMICS), monoclonal
mouse anti-eNOS (BD Biosciences), and polyclonal rabbit anti-
iNOS (NOVUS Biologicals). Secondary antibodies were used in
Dako EnvisionSystem-HRP labeled (Dako, Glostrup, Denmark)
polymer anti-rabbit (or anti-mouse). For the chromogenic reaction,
we used in DAB chromogen and substrate buffer for 10 min at
room temperature. Finally, the sections were washed in distilled
water for 5 min, counterstained with Mayer’s hematoxylin for 15
s, washed again in distilled water, dehydrated with ethanol, cleared
with xylene, and mounted.
Preparation of isolated myocytes and patch-clamp recording. DFA
myocytes were isolated and applied for patch-clamp study as de-
scribed previously (15). Briefly, DFAs were incubated in Ca2-free
NT with 1 mg/ml papain (10–15 min) and 3 mg/ml collagenase
(10–15 min). Tissue chunks were gently agitated with Pasteur pipette,
and the isolated myocytes were transferred into a bath mounted on the
stage of an inverted microscope with perfused bath (0.2 ml, at
Fig. 2. Requirement of voltage-gated L-type
Ca2 channels for HVCDFA. A: pretone con-
ditions induced by K channel blockers [tet-
raethylammonium (TEA) and 4-aminopyri-
dine (4-AP)] were also effective for HVCDFA
(left). In addition, high K (30 and 80 mM)-
induced contractions were also augmented
by hypoxia as summarized in bars at right.
B: HVCDFA was completely inhibited by
nifedipine (1 M L-type Ca2 channel
blocker) applied before as well as after
hypoxia. C: HVCDFA was still observed
after depleting Ca2 stores in sarcoplasmic
reticulum by the applying sarco(endo)plas-
mic reticulum Ca2-ATPase inhibitor cy-
clopiazonic acid (CPA; 10 M). Effects of
CPA pretreatment on HVCDFA are summa-
rized in bars at right.
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Fig. 3. Schematic model of key steps regulating the smooth muscle contractility
and hypothetical O2-sensitive paths for HVCDFA. Numbers in parentheses are the
putative hypoxia-sensing sites where the pharmacological agents and electrophys-
iological test were exerted in this study. 1) depolarizing conductance change,
2) nitric oxide synthase (NOS), 3) NADPH oxidase (NOX), 4) mitochondria
electron transport chain (mETC), 5) reactive oxygen species (ROS) microenvi-
ronment affected by multiple factors, and 6); Ca2-sensitizing mechanisms via
RhoA/Rho-kinase (ROK) and/or protein kinase C (PKC).
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5 ml/min). Whole cell patch-clamp experiments were performed at
room temperature (22–25°C) using a patch-clamp amplifier (Axo-
patch-1C; Axon Instruments, Foster City, CA) and pCLAMP software
v.9.2 and Digidata-1440A (Axon Instruments). The Cs-rich pipette
solution contained the following (in mmol/l): 100 L-aspartic acid, 32
CsCl, 10 EGTA, 10 HEPES, and 5 Mg-ATP, adjusted to pH 7.25 with
CsOH.
Chemicals and solutions. All drugs and chemicals were obtained
from Sigma (St. Louis, MO).
Statistical analysis. Data are shown as means SE with number of
tested arteries indicated as n. Paired or unpaired Student’s t-test was
used for statistical analysis, with P value for significant difference set
at P  0.05.
RESULTS
Basic characteristics of HVCDFA. Isometric tone of DFA
was not changed by hypoxia (3% PO2) alone (data not shown,
n  15). However, under a partial pretone (20–40% of 80-K
contraction) induced by PhE (0.5–1 M), hypoxia induced
additional contraction (HVCDFA) that was similar to the 80-K
contraction (110  5.1%; Fig. 1B). While the development of
HVCDFA was relatively slow (2 min for steady-state contrac-
tion), a rapid relaxation was consistently observed on reoxy-
genation in the presence of PhE (Fig. 1, A and B). The
concentration-dependent contractions of DFA by PhE were
shifted to both leftward and upward directions by hypoxia,
indicating decreased EC50 and increased maximum contraction
(Fig. 1C). Relatively mild hypoxia (PO2 6%) also induced
HVCDFA, and conditions close to anoxia (bubbled with 100%
N2) tended to induce larger HVCDFA than that induced by 3%
PO2 (Fig. 1D).
HVCDFA was also observed with serotonin-induced pretone
conditions (Fig. 1E). Differing from DFA, cerebral, coronary,
and renal arteries did not show HVC but showed no change or
relaxation under serotonin-pretone (Fig. 1, D–F). Serotonin
was used as the pretone agonist because cerebral arteries do not
respond to PhE.
We also tested whether other types of pretone conditions are
effective for HVC. Chemical voltage-depolarization by K
channel blockers (2 mM tetraethylammonium or 5 mM 4-ami-
nopyridine) or by raised KCl (30 or 80 mM)-induced contrac-
tions that were also augmented by hypoxia (Fig. 2A). Hereaf-
ter, DFA was used to investigate the properties and mecha-
nisms of HVC using 3% PO2 as the standard hypoxia condition
with PhE-induced partial contraction (PhE-pretone). HVCDFA
was completely inhibited by L-type Ca2 channel inhibitor
(nifedipine, 1 M) either before or after hypoxia (Fig. 2B). In
contrast, cyclopiazonic acid (CPA, 10 M), an inhibitor of
sarco(endo)plasmic reticulum Ca2-ATPase (SERCA), did not
block HVCDFA (Fig. 2C; n  3). We also confirmed that
pretreatment with thapsigargin (2 M), another inhibitor of
SERCA, did not block HVCDFA (n  2, data not shown).
Because the SERCA inhibitors would impair the Ca2 storing
Fig. 4. Strong augmentation of PhE-pretone
by NOS and soluble guanylate cyclase
(sGC) inhibitors. A: HVCDFA was observed
in the DFA where endothelium was removed
by mechanical abrasion. Functional removal
of endothelium was confirmed by no relax-
ation of DFA by ACh (left). Summary of
HVCDFA in the endothelium denuded DFA
(filled bars) compared with the total sum-
mary (empty bars reused from Fig. 1B).
B: under pretreatment with PhE (1 M), either
NOS inhibitor [nitro-L-arginine methyl ester
(L-NAME), 100 M, top] or sGC inhibitor
[oxadiazole quinoxalin (ODQ), 10 M, bot-
tom] increased the tone of DFA. Additional
hypoxia had no further contraction or even
partial relaxation. Summary of the PhE-pr-
etone augmentation by NOS and sGC inhibi-
tors (right). Control HVCDFA was also con-
firmed in each artery (empty bars).
C81HYPOXIC CONSTRICTION OF SKELETAL ARTERIES VIA INHIBITING NOS
AJP-Cell Physiol • doi:10.1152/ajpcell.00176.2012 • www.ajpcell.org
function of SR, these results indicated that HVCDFA was not
associated with the recruitment of SR Ca2 release. In addi-
tion, the HVCDFA was affected neither by tetrodotoxin (2 M)
nor by guanethidine (10 M, norepinephrine release inhibitor
at synaptic varicosities), excluding the indirect effect of hyp-
oxia via perivascular sympathetic nerves (n  3 and 4, respec-
tively, data not shown).
Mechanisms for HVC. Because pretone was indispensable
for HVCDFA, we suspected that hypoxia either augmented the
intracellular signaling pathways for thecontraction (Fig. 3,
steps 1 and 6) or hampered the relaxing influence such as nitric
oxide synthase (NOS; Fig. 3, step 2). As for the putative O2
sensor of HVCDFA, both NADPH oxidase and mitochondrial
enzymes with heme moiety were suggested (Fig. 3, steps 3 and
4). In the following experiments, each of the above steps was
examined using pharmacological tools.
Previous studies using dog arterial strips suggested that
anoxic conditions induce contraction through an endothelium-
dependent release of putative vasoactive substance(s) (8, 22).
Different from the previous studies, the HVCDFA in rat was
consistently observed after the endothelium was removed by
mechanical abrasion of lumen, which was confirmed from the
absence of vasorelaxation in response to ACh (Fig. 4, A and B).
Interestingly, in the absence of functional endothelium, the
application of NOS inhibitor [nitro-L-arginine methyl ester
(L-NAME), 100 M] induced strong contraction of DFA with
PhE-pretone, upon which no further contraction was induced
by hypoxia (Fig. 4B). Application of NOS-1 (neuronal NOS)
inhibitor (S-methyl-L-thiocitrulline, 1 M) did not affect the
PhE-pretone of DFA (data not shown; n  3). No significant
expression of NOS-2 (iNOS) was confirmed in DFA by im-
munoblot and immunohistochemistry assays (see Fig. 7). Ox-
Fig. 5. Putative role of Ca2 sensitization
mechanism for HVCDFA. A: current to voltage
relation (I/V curves) obtained by applying
ramp-like depolarization (from 	100 to 80
mV) under the whole cell patch-clamp record-
ing using Cs-rich pipette solution. Represen-
tative I/V curves obtained in a DFA myocyte
are shown. Summary of normalized current
amplitudes (I/Icontrol %) at 	80 and 80 mV is
shown as bars at right (n  5). PhE (1 M)
increased membrane conductance (slope of I/V
curve, left). Additional hypoxia did not show
significant effect on the conductance (middle).
*P  0.05. B: representative trace of arterial
tone showing inhibitory effect of RhoA/ROK
inhibitor (1 M Y-27632) on HVCDFA. C: no
effect of PKC inhibitor (0.1 M Go6976) on
HVCDFA. D: summary of the effects of ROK
inhibitors (Y-27632 and fasudil) and PKC in-
hibitors (Go6976, Go6983, Ro31–8220, and
GFX) on HVCDFA.
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adiazole quinoxalin (ODQ; 10 M), a specific inhibitor of
soluble guanylate cyclase (sGC), also markedly augmented the
PhE-pretone of DFA where additional hypoxia induced slight
relaxation (Fig. 4B). The lack of HVC in the presence of
NOS/sGC inhibitors was not due to the limit of contractility
because the maximum inducible tone of DFA was 180% of
80-K contraction (Fig. 1C). A treatment with L-NAME or ODQ
alone did not affect the tone of DFA (data not shown; n  5,
respectively). Such results suggested that NOS-3 (eNOS) and
cGMP-dependent vasorelaxation was simultaneously induced
under the PhE-pretone and hypoxia might have suppressed the
vasorelaxing influence from eNOS/sGC activity.
Since HVCDFA was completely inhibited by nifedipine (Fig.
2B), electrophysiological changes (e.g., activation of nonselec-
tive cationic current in DFA myocyte; Fig. 3, step 1) were
suggested for HVCDFA. Under the whole cell voltage clamp
with CsCl pipette solution, ramp-like depolarization was ap-
plied to obtain current-voltage relation (I/V curve). A pretreat-
ment with 1 M PhE slightly increased the membrane con-
ductance. However, additional hypoxia had no effect on the
membrane conductance of DFA myocytes (Fig. 5A).
The level of smooth muscle contraction is determined by
phosphorylation states of myosin light chain (MLC20-P), which
is affected not only by Ca2/calmodulin and MLC kinase but
also by MLC phosphatase under the regulation by RhoA-
dependent kinase (RhoA/ROK) or PKC. Therefore, we inves-
tigated whether the “Ca2 sensitization” mechanisms play a
role in HVCDFA. ROK inhibitor (1 M Y27632 or 3 M
fasudil) significantly attenuated HVCDFA (Fig. 5, B and D). In
contrast, none of the PKC inhibitors (Go6976, Go6983, Ro
31–8220, and GFX) affected HVCDFA (Fig. 5, C and D).
Taken together, the above results suggested that a hypoxic
inhibition of NOS activity and subsequent recovery of Ca2
sensitivity of myocytes (Fig. 2, steps 2 and 6) could explain the
HVCDFA rather than the electrophysiological changes.
O2-sensing pathway for HVC. As possible physiological O2
sensors in acute hypoxic responses, hemoproteins such as
NADPH oxidase (NOX) and cytochrome-associated proteins
in the mitochondrial electron transport chain process (mETC)
have been suggested in carotid body and pulmonary artery
smooth muscles (1, 18, 20, 28, 26, 31, 34). Diphenylene
iodonium (DPI, 10 M), a nonspecific inhibitor of various
flavoproteins including NOX and mitochondrial cytochrome
oxidase, augmented the PhE-pretone of DFA (Fig. 6, A and D).
Interestingly, additional hypoxia slowly reversed the DPI-
induced contraction (Fig. 6A). Plumbagin has been recently
presented as a NOX4-specific inhibitor (10) and was applied in
a recent study for hypoxic pulmonary vasoconstriction (1).
Similar to the effect of DPI, plumbagin (5 M) induced strong
contraction of DFA with PhE-pretone, and the additional
Fig. 6. Effects of NOX inhibitors on HVCDFA
and expression of NOX4 and NOS-3 in DFA
myocytes. A and B: both DPI (10 M, A) and
plumbagin (5M; B) augmented PhE-pretone in
DFA. Additional hypoxia induced relaxation in-
stead of HPVDFA. C: apocynin (100 M) did
not augment PhE-pretone, and additional
hypoxia induced HVCDFA with reduced
amplitude. D: summary of the effects of
NOX inhibitors on DFA tone and HVCDFA.
E: plumbagin-induced augmented PhE-pretone
was completely reversed by the NO donor [so-
dium nitroprusside (SNP), 1 M] or by the en-
dothelial NO releasing agonist (ACh, 10 M).
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hypoxia induced vasorelaxation (Fig. 6, B and D). While the
above results suggested that an altered activity of NOX under
hypoxia might be involved, HVCDFA was consistently ob-
served in the presence of apocynin (500 M), which is known
to inhibit the formation of active NOX2 complex between p47
and gp91phox (Fig. 6, C and D) (30).
The mimicry of HVCDFA (augmentation of PhE-pretone) by
plumbagin (NOX4 inhibitor) and NOS/sGC inhibitors (L-
NAME and ODQ) suggested that O2-dependent regulations of
NOX4 and NOS/sGC might underlie the O2-sensory mecha-
nism. The plumbagin/PhE-induced strong contraction was com-
pletely reversed by the NO donor sodium nitroprusside (10 M)
or by ACh in the endothelium-intact DFAs (Fig. 6E) suggest-
ing that neither eNOS activation nor NO-dependent cGMP
production was nonspecifically inhibited by the treatment with
plumbagin. The expressions of eNOS (NOS-3) and NOX4, but
not iNOS (NOS-2) expression, were confirmed by immunoblot
assay in the endothelium-denuded DFA (Fig. 7A). Also, more
specific localization of eNOS and NOX4 was investigated in
the immunohistochemistry assay of intact DFA (Fig. 7B). Both
eNOS and NOX4 were strongly expressed in the endothelium.
However, although relatively faint, the expression of eNOS
and NOX4 in the smooth muscle layer was observed compared
with the absence of iNOS signal (Fig. 7B).
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Fig. 7. Immunoblot and immunohistochemistry
assays for NOX4, endothelial NOS (eNOS), and
inducible NOS (iNOS) in DFA. A: representative
cases of immunoblot assays showing the expres-
sion of NOX4 and eNOS while no significant
expression of iNOS in the endothelium abraded
DFA. As for the positive control, the results of
cardiomyocytes (NOX4 and eNOS) and HEK293
cells (iNOS) are shown. Summary of the normal-
ized expression against b-actin (NOX4 and
eNOS) or GAPDH (iNOS) is shown in the bars at
right. B: immunohistochemistry of endothelium
intact DFA for NOX4, eNOS, and iNOS. The
expression of NOX4 and eNOS (brown color) in
endothelium is obvious while faint expressions of
both proteins are also confirmed in the smooth
muscle layer. In contrast, iNOS was expressed
neither in the endothelium nor in the smooth
muscle.
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mETC function could be affected under hypoxia, which
might underlie the HVCDFA. In DFA, inhibitors of mETC
[rotenone (100 nM), the complex I inhibitor myxothiazol (100
M). the complex III inhibitor cyanide (NaCN, 0.5 mM), and
complex IV inhibitor] commonly suppressed HVCDFA (Fig. 8).
The inhibitory effect of rotenone was strongest among the
tested agents. Different from the effects of eNOS and NOX
inhibitors, none of the mETC inhibitors mimicked HVCDFA.
Then, we investigated whether reactive oxygen species
(ROS) scavengers or antioxidants affect HVCDFA. A variety of
agents were tested; tempol (5 mM), N-acetyl cysteine (1 mM),
ascorbic acid (vitamin C, 1–10 mM), trolox (0.2 mM), tiron (1
mM), ebselen (10 M), and PEG-catalase (1,000 IU/ml). How-
ever, none of them mimicked or inhibited HVCDFA (Fig. 9, A and
B). In contrast with the ineffectiveness of ROS scavengers, an
exogenous application of H2O2 affected the DFA under pre-
treatment with PhE. The PhE-pretone was augmentation by
H2O2 up to 20 M whereas attenuation at the higher concen-
tration (Fig. 9, D and E). HVCDFA was still observed with
H2O2 up to 20 M. However, no HVCDFA occurred under the
pretreatment with 50 M H2O2 (Fig. 9, D and E).
DISCUSSION
In this study, we first report the HVC in rat skeletal arteries
(HVCDFA). The hypoxia-induced or -augmented vasoconstric-
tion has been extensively investigated in pulmonary arteries,
called hypoxic HPV. From previous studies on the cellular
mechanisms of HPV, it is generally believed that the pulmo-
nary arterial smooth muscle cells are both sensors and effectors
for the HPV (28, 31, 33). Because HVCDFA was consistently
observed in the absence of functional endothelium, the sensor
for HVCDFA seemed to be also equipped within the smooth
muscle cells.
Previously, we found that the HPV of isolated pulmonary
arteries from rats specifically requires thromboxane A2 as a
pretone agent (35). Similarly, a partial pretone was also indis-
pensable for the HVCDFA. The requirement of pretone indi-
cates that hypoxia did not directly trigger constrictive signals
but sensitized DFA to contraction signals or alleviated relaxing
actions intrinsic to DFA.
O2-sensing mechanisms of vascular myocytes have been
most extensively investigated in pulmonary arterial smooth
muscle cells, and those mechanisms might be categorized into
1) O2-sensitive ion channel hypotheses and 2) ROS-mediated
regulation of Ca2 sensitization. Each category can be further
divided according to specific molecule(s) claimed by research
groups. As for the underlying mechanisms of HVCDFA, we
initially suspected that hypoxia induced depolarization of myo-
cytes because the HVC was completely suppressed by the
L-type voltage-operated calcium channel (VOCCL) inhibitor
nifedipine (Fig. 2B). However, since the membrane conduc-
tance of DFA myocytes was not increased by hypoxia (Fig.
5A), our interpretation is that hypoxia did not directly augment
membrane depolarization. Consistently, HVCDFA was still ob-
served under the chemical voltage clamp conditions like K
channel blocker and high K bath solution (Fig. 2A). This
suggests that hypoxia augments the contractions induced by
various conditions such as VOCCL activation. In this respect,
the complete inhibition of HVCDFA by nifedipine could be
interpreted as blockade of the primary condition.
Alleviation of NO-dependent vasorelaxation by hypoxia?
The strong contraction induced by L-NAME upon PhE-pretone
of endothelium-denuded DFA indicated that the NOS activity
in smooth muscle might partly attenuate the vascular tone
induced by PhE (Fig. 4). No significant HVC in the presence of
L-NAME suggested that NOS might have been also targeted by
hypoxia (Fig. 4B). Since the maximum tone of DFA could
reach to 200% of 80-K contraction (Fig. 1C), the lack of HVC
upon L-NAME-induced tone (120% of 80-K contraction) was
not likely due to the limit of contractility. Although conven-
tional wisdom was that only endothelial cells express NOS
(i.e., NOS3), recent studies have shown that arterial myocytes
also express multiple subtypes of NOS (5). Since a pretreat-
ment with NOS1 (neuronal NOS)-specific inhibitor (SMTC)
Fig. 8. Effects of mETC inhibitors on HVCDFA.
A–C: representative traces of HVCDFA under
treatment with rotenon (100 nM), myxothiazol
(100 M), and NaCN (500 M). Rotenone and
NaCN abolished HVCDFA, and myxothiazol de-
creased the amplitude of HVCDFA. D: summary
of the effects of mETC inhibitors on HVCDFA.
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had no effect on DFA contractility and the HVCDFA (data not
shown), NOS3 (eNOS) or NOS2 (iNOS) could be an important
player for HVCDFA. Both immunoblot assay and immunohis-
tochemistry assays indicated the expression of eNOS, although
relatively faint, in the medial layer of DFA (Fig. 7). Because
eNOS is activated by Ca2/calmodulin-dependent mechanism,
it is supposed that the pretone conditions would activate the
weakly expressed eNOS in the myocytes as well as predomi-
nant Ca2-dependent vasoconstriction mechanisms. In such
conditions, hypoxic inhibition of eNOS activity could signifi-
cantly augment the pretone contraction (Fig. 10). The hypo-
thetical model was also consistent with the dependence of
L-NAME- and ODQ-induced contractions on pretone condi-
tions and the sensitivity to the VOCCL inhibitor (Fig. 4). As for
the mechanism of putative hypoxic inhibition of eNOS, how-
ever, experimental clues are still lacking except the indirect
results obtained from pharmacological inhibitors of NOX and
mETC.
DFA showed transient relaxation on reoxygenation in the
presence of PhE. The transient relaxation on reoxygenation
(posthypoxic relaxation) suggested either transient activation
of relaxing mechanism or revelation of underlying hypoxia-
induced relaxation that was outbalanced by HVC before re-
oxygenation. In the presence of DPI and plumbagin combined
with PhE-pretone, relatively strong relaxation was induced by
hypoxia instead of HVCDFA. Such results also suggest dual
effects of hypoxia on the tone of skeletal arteries.
O2-sensing mechanism for HVCDFA. Because the pharmaco-
logical agents (e.g., NOX inhibitors) used in this study have
potentially nonspecific and indirect effects, one has to be very
Fig. 9. No effects of ROS scavengers on
HVCDFA. A and B: representative traces of
HVCDFA under treatment with ascorbic acid
(1 mM, A) and tempol (5 mM; B). C: sum-
mary of the effects of various ROS scaven-
gers [0.2 mM tempol, 1 mM N-acetyl cys-
teine (NAC), 1 mM vitamin C (Vit C), 10
M ebselen, 1 mM tiron, and 1,000 IU/ml
PEG-catalase] on HVCDFA. Number of tested
vessels is indicated in each bar. D: effects of
H2O2 on DFA tone and HVCDFA. Applica-
tion of 10 and 20 M H2O2-induced tonic
contraction while 50 M H2O2 induced a
transient contraction on top of PhE-pretone.
Interestingly, hypoxia still induced HVCDFA
with 10 and 20 M H2O2 whereas hypoxic
relaxation was observed with 50 M H2O2 in
the same vessel. E: summary of the effects of
various concentrations of H2O2 on PhE-pr-
etone and HVCDFA. Number of tested vessels
is indicated in each bar.
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careful in the interpretations (28). Admitting this limitation,
from the strong augmentation of PhE-pretone by DPI and
plumbagin but not by apocynin, we suggested that a putative
hypoxic inhibition of NOX4 might be a proximal step for
HVCDFA. Because a treatment with plumbagin affected neither
the vasorelaxing effects of NO donor (sodium nitroprusside,
1 M) nor the endothelium-dependent relaxation by ACh (Fig.
6E), NOX4 or NOX4-associated molecules seem to be proxi-
mal to NOS/sGC in the signaling steps for HVCDFA. In
addition, this result might also suggest that plumbagin did not
nonspecifically augment the contractility of DFA.
NOX4 is a constitutively active member of NOX family, and
therefore, a direct effect of hypoxia on the activity of NOX4
was supposed to be a decreased production of superoxide
anions (O2	) that are immediately converted into H2O2 by
superoxide dismutase. In addition, it has been reported that
H2O2 stimulate eNOS (6, 29). In the presence of a relatively
high concentration of H2O2 (20 M), both PhE-pretone and
HVCDFA was abolished (Fig. 9, D and E). Taken together, an
attractive interpretation was that the hypoxic inhibition of
NOX4 might weaken the H2O2-mediated facilitation of eNOS
activity and thereby reveal the full contraction by pretone
conditions, i.e., HVCDFA. Unfortunately, however, ROS scav-
engers did not mimic the effect of NOX4 inhibitors: the
pretreatment with tempol, ebselen, tiron, and catalase only
partly attenuated or had no effect on HVCDFA (Fig. 9, A–C).
The concentration-dependent dual effects of H2O2 further com-
plicated interpretations based on the model of NOX4/H2O2/
eNOS signaling (Fig. 9, D and E). One might propose a bold
hypothesis that NOX4 conveys the PO2 state to effector (e.g.,
eNOS) via a “nonenzymatic mechanism” without the mediat-
ing role of H2O2. Previously, we showed that NOX4-depen-
dent hypoxic inhibition of two-pore domain K channel
(TASK1) is a ROS-independent mechanism (21). However,
rigorous molecular evidence is definitely required for such
hypothesis, which has not accomplished yet.
Although precise mechanism is not known yet, intact mito-
chondrial function was indispensable for maintaining the tone
of DFA as well as for HVCDFA. The potent suppression of
PhE-pretone and HVCDFA by mETC inhibitors suggested that
the mitochondria might also play as an O2 sensor for HVCDFA
as suggested in pulmonary and coronary arteries (12, 22).
Although still controversial, the production of superoxide an-
ion during mETC process is claimed to be increased by
hypoxia (18, 20, 22). Different from H2O2, the increased
superoxide anions could impair the NOS function as well as
scavenging NO (26). The insignificant effect of ROS scaven-
gers on HVCDFA might be interpretable based on the colocal-
ization of eNOS in the outer membrane of mitochondria (13).
In this respect, another hypothetical model is that spillover of
superoxide anion from mETC under hypoxia might impair the
eNOS/sGC activity in DFA (Fig. 10). However, fundamental
limitation in the interpretation of the results with mETC inhib-
itors is that the impaired energy metabolism might nonspecifi-
cally affect the contractility of arteries.
Physiological roles of HVC in skeletal arteries. An in vivo
human study demonstrated that systemic hypoxia augmented
forearm vasodilation during exercise (4, 8). At a first glance,
therefore, HVCDFA in rat skeletal artery was counterintuitive to
the physiological role of arteries perfusing muscular tissues
with widely variable metabolic rates. The HVCDFA phenome-
non might contribute to balancing excessive vasodilation of
skeletal arteries under metabolic inhibition of the adjacent
tissue, especially under the tonic influence from the sympa-
thetic nervous system. It has been recently demonstrated that
constitutive activation of -adrenoreceptors in skeletal muscle
can restrict the spread of dilatation within microvascular resis-
tance networks (17).
Strenuous exercise might induce a competition between
active skeletal muscles, myocardium, and central nervous sys-
tem for a limited amount of maximum perfusion. A plausible
role of HVC might be the maintenance of vital organ perfusion
against the circulatory emergency conditions (11, 23). For
example, in systemic hypoxia combined with loss of blood
volume, the HVC of skeletal arteries under increased sympa-
thetic tone would divert the limited blood flow to vital organs
such as brain, heart, and kidney where no HVC was observed
in their feeding arteries (Fig. 1, F–H).
In summary, we report HVCDFA in rats may be mediated by
the attenuation of PO2-dependent signaling pathways of eNOS/
sGC in smooth muscle. Since ROS scavengers did not com-
pletely inhibit HVC, the signaling mechanism between the
candidate O2 sensors (NOX4 and mETC) and eNOS/sGC
remains elusive. The HVC of skeletal arteries may prevent the
imbalance between the cardiac output and the skeletal blood
flow under severe exercise or under emergent hypoxia com-
bined with increased sympathetic tone.
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O2-sensing mechanisms.
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